Longevity & Aging · Diets · Metabolic & Cardiometabolic
fasting or very-low-calorie diet reverses type 2 diabetes
In plain terms: Can a strict diet or fasting actually put type 2 diabetes into lasting remission, not just control it?
Yes — substantial weight loss via very-low-calorie diet or carbohydrate restriction produces genuine, durable remission with beta-cell recovery in a meaningful fraction of people, though remission is weight-loss-driven not fasting-specific and often relapses if weight returns.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Lim 2011 · Diabetologia | observational | supports | moderate | Counterpoint: 8-week 600-kcal VLCD normalised fasting glucose, first-phase insulin secretion, and reduced pancreatic/hepatic fat — mechanistic proof of beta-cell recovery. |
| Leslie 2016 · BMC Fam Pract | mechanism | supports | moderate | DiRECT protocol formalises twin-cycle hypothesis: ectopic liver/pancreas fat drives T2D, removable by about 15 kg loss to restore normoglycaemia. |
| Riddle 2021 · Diabetes Care | observational | mixed | high | ADA/EASD consensus defines remission as HbA1c less than 6.5% for 3+ months off glucose-lowering drugs — endorses remission as real but stresses it is often not permanent. |
| Wu 2025 · Front Endocrinol | observational | mixed | low | 3-yr follow-up of intermittent energy restriction: remission maintainable without ongoing intervention in normal-BMI subset, but relapse tracks weight regain. |
| Hallberg 2018 · Diabetes Ther | observational | supports | moderate | Virta 1-yr: very-low-carb continuous care lowered HbA1c and cut diabetes medication in most; 60% reversal metric but non-randomised, single-arm design. |
| Wang 2026 · Food Res Int | RCT | supports | low | Small crossover RCT: 7-day very-low-calorie high-fibre lead-in improved HbA1c and gut microbiota in newly-diagnosed T2D, supporting early-window reversibility. |
| Athinarayanan 2019 · Front Endocrinol | observational | mixed | moderate | Virta 2-yr non-randomised: sustained HbA1c/medication reductions but attrition and no control arm limit remission claims; not ADA-defined remission off all drugs. |
| Lakhani 2025 · Prim Care Diabetes | meta-analysis | mixed | moderate | Review: intermittent fasting and continuous caloric restriction give comparable glycemic/weight benefit — no clear superiority of fasting over calorie restriction. |
| Lean 2019 · Lancet Diabetes Endocrinol | RCT | supports | high | DiRECT 2-yr: 36% of VLCD intervention participants in remission vs 3% control, with 64% remission among those maintaining greater than 10 kg loss. |
| Yang 2023 · J Clin Endocrinol Metab | RCT | supports | moderate | Fasting-specific RCT: intermittent calorie-restricted (CMNT) diet achieved 47.2% ADA-defined remission at 12 months vs 2.8% control — direct fasting evidence. |
| Lean 2024 · Lancet Diabetes Endocrinol | observational | mixed | moderate | DiRECT 5-yr extension: remission fell to about 13% intervention vs 5% control as weight was regained, showing remission is real but durability wanes. |
| McKenzie 2024 · Diabetes Res Clin Pract | observational | mixed | low | Virta 5-yr extension: benefits attenuated with heavy attrition (about 46% retained), tempering durable-remission claims from low-carb approach. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.